Please ensure Javascript is enabled for purposes of website accessibility

Why Cardlytics Is Plunging 25% Today

By James Brumley – Aug 4, 2021 at 11:30AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors are punishing this small company for quarterly results that shouldn't be all that surprising.

What happened

Shares of online advertising outfit Cardlytics (CDLX -0.98%) are down 24.9% headed into the middle of Wednesday's trading action following a disappointing Q2 earnings report.

So what

For the three-month stretch ending in June, Cardlytics posted a per-share operating loss of $0.39 on revenue of $58.9 million. The top line was up 109% year over year, but it fell short of consensus estimates of $62.9 million. The bottom line was better than the expected loss of $0.65 per share, but had still worsened by a penny compared to the year-ago figure.

Worried investor staring at a computer screen.

Image source: Getty Images.

The company is also guiding for revenue of between $57 million and $66 million for the quarter currently underway, although analysts had collectively been modeling a top line of $71.0 million. Any of those figures would be a marked slowdown from last quarter's triple-digit growth pace.

Now what

Had shares taken today's tumble immediately following a run-up to frothy, record-breaking prices, it would be easy to suspect more downside in store. That's not the case, though. Shares were already down 26% from February's high headed into Tuesday's post-close announcement, suggesting investors already knew second-quarter numbers weren't going to be thrilling. With Wednesday's drubbing, the stock's not only down 44% for the past six months but may well be descending as you read this.

It's still a risky name to be sure, and not appropriate for many investors. The company's fundamental story hasn't changed, though, and its growth trajectory isn't dramatically different from what it appeared to be before Tuesday. If it was ownable then, this new lower price makes Cardlytics even more ownable now.

James Brumley has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cardlytics, Inc. Stock Quote
Cardlytics, Inc.
CDLX
$4.03 (-0.98%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
356%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.